Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 2
2006 1
2007 3
2009 1
2010 1
2011 3
2012 2
2013 2
2014 3
2015 6
2016 1
2017 1
2018 5
2019 5
2020 5
2021 7
2022 4
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial.
Heuser M, Smith BD, Fiedler W, Sekeres MA, Montesinos P, Leber B, Merchant A, Papayannidis C, Pérez-Simón JA, Hoang CJ, O'Brien T, Ma WW, Zeremski M, O'Connell A, Chan G, Cortes JE. Heuser M, et al. Among authors: chan g. Ann Hematol. 2021 May;100(5):1181-1194. doi: 10.1007/s00277-021-04465-4. Epub 2021 Mar 19. Ann Hematol. 2021. PMID: 33740113 Free PMC article. Clinical Trial.
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial.
Sekeres MA, Montesinos P, Novak J, Wang J, Jeyakumar D, Tomlinson B, Mayer J, Jou E, Robak T, Taussig DC, Dombret H, Merchant A, Shaik N, O'Brien T, Roh W, Liu X, Ma W, DiRienzo CG, Chan G, Cortes JE. Sekeres MA, et al. Among authors: chan g. Leukemia. 2023 Oct;37(10):2017-2026. doi: 10.1038/s41375-023-02001-z. Epub 2023 Aug 21. Leukemia. 2023. PMID: 37604981 Free PMC article. Clinical Trial.
The impacts of COVID-19 on glaucoma patient outcomes as assessed by POEM.
Pujari R, Chan G, Tapply I; Addenbrookes Glaucoma COVID response consortium; Bourne RR. Pujari R, et al. Among authors: chan g. Eye (Lond). 2022 Mar;36(3):653-655. doi: 10.1038/s41433-021-01425-0. Epub 2021 Feb 9. Eye (Lond). 2022. PMID: 33564139 Free PMC article. No abstract available.
SCALP syndrome: What is it and its ophthalmic manifestations.
Chan GZP, Stevenson L, Sinkar S, Lam GC. Chan GZP, et al. Am J Ophthalmol Case Rep. 2018 Apr 21;11:10-12. doi: 10.1016/j.ajoc.2018.04.018. eCollection 2018 Sep. Am J Ophthalmol Case Rep. 2018. PMID: 30051001 Free PMC article.
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes.
Sekeres MA, Schuster M, Joris M, Krauter J, Maertens J, Breems D, Gyan E, Kovacsovics T, Verma A, Vyas P, Wang ES, Ching K, O'Brien T, Gallo Stampino C, Ma WW, Kudla A, Chan G, Zeidan AM. Sekeres MA, et al. Among authors: chan g. Ann Hematol. 2022 Aug;101(8):1689-1701. doi: 10.1007/s00277-022-04853-4. Epub 2022 Apr 30. Ann Hematol. 2022. PMID: 35488900 Clinical Trial.
55 results